LEAF interviews David Sinclair about NMN trials and epigenetics
Lifespan.io (LEAF) - 10-Sep-2019He's optimistic that human trials will convert the majority of people who are skeptical or unaware
Join the club for FREE to access the whole archive and other member benefits.
World's aging researchers unite to accelerate breakthroughs in longevity
First Global Research Academy Taking on the ‘Age Old’ Question
Why must we age and what can we do to slow it?
This question has haunted humanity from the beginning of conscious thought. Science is currently at a threshold moment; the biology of aging has never been as understood, and as poised for innovation and disruption as it is today. The Academy is harnessing the collective power of 16 of the world’s brightest and most distinguished gerontologists to ensure that breakthroughs in aging research are not only accelerated but also made accessible to all.
March 2024: Matt Kaeberlein renounced his membership in protest at AHLR president David Sinclair's claim to have reversed ageing in dogs
Visit website: https://www.ahlresearch.org/
Details last updated 04-Jan-2020
Professor in the Departments of Developmental and Molecular Biology and of Medicine of the Albert Einstein College of Medicine.
Professor in the Departments of Developmental and Molecular Biology and of Medicine of the Albert Einstein College of Medicine.
Professor at the Salk Institute for Biological Studies, Director at San Diego Institute of Science, Altos Labs
He's optimistic that human trials will convert the majority of people who are skeptical or unaware
Will campaign to treat ageing as a disease